Kura Oncology | 8-K: Kura Oncology Reports Second Quarter 2024 Financial Results
Kura Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Kura Oncology Reports First Quarter 2024 Financial Results
Kura Oncology | DEF 14A: Definitive information statements
Kura Oncology | DEFA14A: Others
Kura Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Kura Oncology | 8-K: Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
Kura Oncology | S-3: Registration statement for specified transactions by certain issuers
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Current report
Kura Oncology | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Kura Oncology | 8-K: Kura Oncology Reports Third Quarter 2023 Financial Results
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Kura Oncology Reports Second Quarter 2023 Financial Results
Kura Oncology | 8-K: Current report
Kura Oncology | 8-K: Current report
Kura Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data